9 September 2026
The arrival of nirsevimab, a long-acting monoclonal antibody, promises to rewrite the narrative of RSV prevention.
Tag: respiratory Syncytial Virus (RSV)
17 July 2026
Like many other respiratory diseases, RSV is highly contagious – among infants, two out of three children experience their first infection before 12 months of age.
8 June 2026
Letter
The Deadly Dance: Why Beating RSV Means Also Fighting Pneumococcus — Dr Musa Mohd Nordin, Dr Zulkifli Ismail & Dr Cheang Hon Kit
Optimal control of childhood respiratory disease will not come from targeting RSV or pneumococcus alone, but both simultaneously.
3 June 2026
Letter
Protecting Malaysia’s Children From An Invisible Threat — Dr Musa Mohd Nordin & Dr Zulkifli Ismail
RSV is the leading cause of hospitalisation for all infants in Malaysia, yet it remains under-discussed and unaddressed.
1 October 2025
Dr Azmee Mohd Ghazi explains why protecting against RSV belongs in Malaysia’s cardiovascular playbook, other than influenza and pneumococcal infections.
16 January 2025
Letter
Advancements In The Prevention Of Respiratory Syncytial Virus (RSV) Infection In Children — Dr Musa Mohd Nordin & Dr Husna Musa
RSV causes a high disease burden for infants globally. Virtually all children will be infected with RSV by 2 years of age.